SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001193125-21-340198
Filing Date
2021-11-24
Accepted
2021-11-24 14:27:55
Documents
3
Group Members
GARLAND INVESTMENTS, L.P.LAGUNITA BIOSCIENCES LLCLAGUNITA, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13D d268836dsc13d.htm SC 13D 85984
2 EX-A d268836dex99a.htm EX-99.A 3774
3 EX-B d268836dex99b.htm EX-99.B 5822
  Complete submission text file 0001193125-21-340198.txt   96995
Mailing Address 490 ARSENAL WAY SUITE 120 WATERTOWN MA 02472
Business Address 490 ARSENAL WAY SUITE 120 WATERTOWN MA 02472 781-996-5252
Kala Pharmaceuticals, Inc. (Subject) CIK: 0001479419 (see all company filings)

IRS No.: 270604595 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-90054 | Film No.: 211445132
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O 1LIFE HEALTHCARE, INC. ONE EMBARCADERO CENTER, SUITE 1900 SAN FRANCISCO CA 94111
Business Address
Blumenkranz Mark S. (Filed by) CIK: 0001614869 (see all company filings)

Type: SC 13D